We screened CCL22-regulated pathway kinases in ESCC cells using a phosphokinase array and found that several kinases were activated by CCL22 (50 ng/ml) in KYSE410 cells, especially those involved in FAK/AKT signaling (Fig. 4A). The gene discussed is PTK2; the disease is esophageal squamous cell carcinoma.